Clinical Trial Update: Pilot Study of OXP005 to Assess Gastroduodenal Irritation [Phase 1]

View source ↗

Summary

Phase 1 pilot study assessing gastroduodenal irritation risk for OXP005; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroduodenal Erosions

Drugs mentioned

• OXP005

Snippet

Sponsor: Oxford Pharmascience Ltd | Conditions: Gastroduodenal Erosions | Phase 1 | Status: COMPLETED